DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2006

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended

31/03/2006
Quarter1
Financial Year End31/12/2006
The figureshave not been audited

Attachments

DBIOTEC-Q1 18052006.xls
109 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2006 
31/03/2005 
31/03/2006 
31/03/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
27,414
22,205
27,414
22,205
2Profit/(loss) before tax
10,461
7,468
10,461
7,468
3Profit/(loss)
after tax and minority
interest
7,624
5,905
7,624
5,905
4Net profit/(loss) for
the period
7,624
5,905
7,624
5,905
5Basic earnings/(loss) per share (sen)
5.47
4.47
5.47
4.47
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7Net assets per share attributable to ordinary equity holders of the parent (RM)

1.0600
1.0100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced18 May 2006  
CategoryFinancial Results
Reference NoCS-060518-36610